Boston Scientific Says Taxus No More Risky Than Cypher

Boston Scientific released a study showing its Taxus drug-eluting stent is no more likely to cause blood clots after one year than Johnson & Johnson's Cypher, reports the Boston Globe. J&J has been saying clotting is less likely to occur in Cypher than Taxus. European studies have shown that as many as 2.9% of drug-eluting stents cause clotting within three years.